Goldenstein Leonard, Driver Todd H, Fried Linda F, Rifkin Dena E, Patel Kushang V, Yenchek Robert H, Harris Tamara B, Kritchevsky Stephen B, Newman Anne B, Sarnak Mark J, Shlipak Michael G, Ix Joachim H
Division of Nephrology and Hypertension, Department of Medicine, University of California, San Diego, CA; Nephrology Section, Veterans Affairs San Diego Healthcare System, San Diego, CA.
Department of Medicine, University of California, San Francisco, San Francisco, CA.
Am J Kidney Dis. 2014 Oct;64(4):542-9. doi: 10.1053/j.ajkd.2014.05.009. Epub 2014 Jun 18.
In populations with prevalent chronic kidney disease (CKD), lower serum bicarbonate levels are associated with more rapid CKD progression, but whether lower bicarbonate levels also are associated with risk of incident estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m(2) and CKD progression among community-living persons with predominantly preserved kidney function is unknown.
Longitudinal observational cohort study.
SETTING & PARTICIPANTS: Well-functioning community-living elders aged 70-79 years at inception.
Serum bicarbonate level measured at the time of collection by arterialized venous blood sample using an arterial blood gas analyzer.
Change in eGFR over 7 years, and new eGFR < 60 mL/min/1.73 m(2) with a rate of loss of at least 1 mL/min/1.73 m(2) per year.
Linear and logistic regressions were used to evaluate associations of baseline serum bicarbonate level with change in eGFR and incident eGFR < 60 mL/min/1.73 m(2).
At baseline, mean eGFR was 84 ± 16 (SD)mL/min/1.73 m(2), and serum bicarbonate level was 25.2 ± 1.9 mmol/L. Compared with participants with higher bicarbonate concentrations (23.0-28.0 mmol/L), those with bicarbonate concentrations < 23 mmol/L (n = 85 [8%]) lost eGFR0.55 (95% CI, 0.13-0.97) mL/min/1.73 m(2) per year faster in models adjusted for demographics, CKD risk factors, baseline eGFR, and urine albumin-creatinine ratio. Among the 989 (92%) participants with baseline eGFRs > 60 mL/min/1.73 m(2), 252 (25%) developed incident eGFRs < 60 mL/min/1.73 m(2) at follow-up. Adjusting for the same covariates, participants with bicarbonate concentrations < 23 mmol/L had nearly 2-fold greater odds of incident eGFRs < 60 mL/min/1.73 m(2) (OR, 1.72; 95% CI, 0.97-3.07) compared with those with higher bicarbonate concentrations.
Only 2 measurements of kidney function separated by 7 years and loss to follow-up due to intervening mortality in this elderly population.
Lower serum bicarbonate concentrations are associated independently with decline in eGFR and incident eGFR < 60 mL/min/1.73 m(2) in community-living older persons. If confirmed, serum bicarbonate levels may give insight into kidney tubule health in persons with preserved eGFRs and suggest a possible new target for intervention to prevent CKD development.
在患有慢性肾脏病(CKD)的人群中,血清碳酸氢盐水平较低与CKD进展较快相关,但在主要肾功能尚保存的社区居住人群中,较低的碳酸氢盐水平是否也与估算肾小球滤过率(eGFR)<60 mL/min/1.73 m²的发生风险及CKD进展相关尚不清楚。
纵向观察性队列研究。
初始时功能良好的70 - 79岁社区居住老年人。
使用动脉血气分析仪通过动脉化静脉血样本在采集时测量的血清碳酸氢盐水平。
7年内eGFR的变化,以及新出现的eGFR<60 mL/min/1.73 m²且每年至少下降1 mL/min/1.73 m²。
采用线性和逻辑回归来评估基线血清碳酸氢盐水平与eGFR变化及新发eGFR<60 mL/min/1.73 m²之间的关联。
基线时,平均eGFR为84±16(标准差)mL/min/1.73 m²,血清碳酸氢盐水平为25.2±1.9 mmol/L。与碳酸氢盐浓度较高(23.0 - 28.0 mmol/L)的参与者相比,碳酸氢盐浓度<23 mmol/L(n = 85 [8%])的参与者在根据人口统计学、CKD危险因素、基线eGFR和尿白蛋白 - 肌酐比值进行调整的模型中,每年eGFR下降速度快0.55(95%可信区间,0.13 - 0.97)mL/min/1.73 m²。在989名(92%)基线eGFR>60 mL/min/1.73 m²的参与者中,252名(25%)在随访时出现新发eGFR<60 mL/min/1.73 m²。在调整相同协变量后,与碳酸氢盐浓度较高的参与者相比,碳酸氢盐浓度<23 mmol/L的参与者出现新发eGFR<60 mL/min/1.73 m²的几率几乎高出1倍(比值比,1.72;95%可信区间,0.97 - 3.07)。
仅进行了两次间隔7年的肾功能测量,且该老年人群因中间死亡率导致失访。
在社区居住的老年人中,较低的血清碳酸氢盐浓度独立地与eGFR下降及新发eGFR<60 mL/min/1.73 m²相关。如果得到证实,血清碳酸氢盐水平可能有助于了解eGFR保存人群的肾小管健康状况,并提示一个可能预防CKD发生的新干预靶点。